Spiral computed tomography angiography in the evaluation of hepatocellular carcinoma vascularity and malignancy degree

Abstract

Aim. To study the vascularity and malignancy degrees of hepatocellular carcinoma using spiral computed tomography angiography considering its morphological differentiation and tumor size. Methods. A comprehensive clinical and radiological examination of 300 patients (males - 170 (56.6%), females - 130 (43.4%), mean age 52.0±3.2 years) with hepatocellular carcinoma, who were picked out from 2550 patients with malignancies treated in 2005-2013, was performed. Liver cirrhosis was diagnosed in 70 (23.33%) out of 300 patients with hepatocellular carcinoma. The features of tumor bloodflow were assessed using color Doppler ultrasonography and spiral computed tomography angiography (by 4 phases of examination) considering tumor size and tumor morphological differentiation. Results. According to the morphological study results of samples from 123 patients, high-grade differentiated hepatocellular carcinoma was diagnosed in 40 patients, moderately differentiated - in 53, poorly differentiated - in 30 patients. A correlation of tumor vascularity with histological differentiation degree and tumor size was revealed. The difference in high-grade differentiated hepatocellular carcinoma maximal computed tomography density increment gradients at arterial phase compared to liver parenchyma maximal computed tomography density increment was 17 Hounsfield units in tumors sized up to 5 cm and 12 Hounsfield units in 32 (80%) of 40 patients with tumors sized over 5 cm. Thus, high-grade differentiated hepatocellular carcinoma was associated with increased vascularity in 80.0%, normal vascularity - in 8.0%, low vascularity - in 12.0% of cases. The difference in moderately differentiated hepatocellular carcinoma computed tomography density increment gradients compared to liver parenchyma was assessed as 20 and 25 Hounsfield units in tumors with the corresponding size in 45 (89.4%) out of 53 patients. Moderately differentiated hepatocellular carcinoma was associated with increased vascularity in 89.4%, normal vascularity - in 4.0%, low vascularity - in 6.6% of cases. Poorly differentiated hepatocellular carcinoma was associated with increased vascularity only in 7 out of 30 patients. Conclusion. The correlation of tumor vascularity with histological differentiation degree and tumor size was revealed. Increased vascularity was observed in high-grade differentiated and moderately differentiated hepatocellular carcinoma, low vascularity - mainly in poorly differentiated hepatocellular carcinoma.

Keywords

spiral computed tomography angiography / contrast enhancement / hepatocellular carcinoma / vascularity / histological differentiation

References

[1] Акберов Р.Ф., Зыятдинов К.Ш., Варшавский Ю.В., Зогот С.Р. Гепатоцеллюлярный рак (эпидемиология, лучевая диагностика, современные аспекты лечения) // Практ. мед. - 2013. - №2. - С. 112-115.

[2] Акберов Р.Ф., Зыятдинов К.Ш., Варшавский Ю.В. и др. Комплексная лучевая диагностика патологии гепатобилиопанкреатопилородуоденальной зоны. - Казань: ИД «Меддок», 2013. - 288 с.

[3] Бахмутова Е.Е. Возможна ли достоверная диагностика однородно накапливающих гиперваскулярных образований печени одним из томографических методов (КТ, МРТ)? // Мед. визуализац. - 2010. - №3. - С. 50-58.

[4] Туманова С.Р., Кармазановский Г.Г., Щеголев А.И. Количественная и качественная КТ-характеристика особенности кровоснабжения гепатоцеллюлярного рака разной степени дифференцировки // Мед. визуализац. - 2013. - №2. - С. 97-103.

[5] Ярошенко Е.Б., Бурневич Э.З., Мойсюк И.Т. Роль вирусных гепатитов в развитии гепатоцеллюлярной карциномы // Практ. онкол. - 2008. - Т. 9, №4. - С. 189-194.

[6] Bruix J., Sherman M. Practice Guidelines Comittu, American Association for the study liver diseases. Management of hepatocellular carcinoma // Hepatology. - 2005. - Vol. 42. - P. 1208-1236.

[7] Chiba T., Toknuye K., Matsuuuzaki Y. et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients // Clin. Canc. Res. - 2005. - Vol. 11. - P. 3799-3805.

[8] Haushi M., Matsui O., Veda K. et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood evaluated with CT during intrarterial injection of contrast material // Radiology. - 2002. - Vol. 255. - P. 143-149.

[9] Kew M.C. Epidemiology of chronic hepatitis B virus infextion, hepatocellular carcinoma, and hepatitis B virus - induced hepatocellular carcinoma // Pathology. - 2010. - Vol. 58. - P. 273-277.

[10] Kudo M. Atypical large well-differentited hepatocellular carcinona a with benign nature: a new clinical antity // Intervirology. - 2004. - Vol. 47. - P. 227-237.

[11] Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology // J. Gastroenterol. - 2009. - Vol. 44, suppl. XIX. - P. 112-118.

[12] Lapi E., Geschwund J.F.H. Intraarterial therapies for hepatocellular carcinoma: where do we Stand? // Ann. Surg. Oncol. - 2010. - Vol. 17. - P. 1234-1246.

[13] Matsui O. Imaging multi step human hepatocarcinogenesis by CT during intraarterial contrast injection // Intervirology. - 2004. - Vol. 47. - P. 271-276.

[14] Sahani D.V., Holakerr N.S., Mueller P.R., Ihu A.X. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience // Radiology. - 2007. - Vol. 1243. - P. 736-743.

[15] Saar B., Kelner-Weldon F. Radiological diagnosis of hepatocellular carcinoma // Liverinternational. - 2008. - Vol. 28. - P. 189-199.

[16] Yang J.D., Roberts L.P. Epidemiology amnd management of hepatocellular carcinoma // Infect. Dis. Clin. N. Am. - 2010. - Vol. 24. - P. 889-919.

RIGHTS & PERMISSIONS

Zogot S.R., Akberov R.F., Mikhaylov M.K.